Karin E M Diderich Selected Research

dichlorobis(azomycin)platinum II

1/2022	Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study.
1/2021	Patient-friendly integrated first trimester screening by NIPT and fetal anomaly scan.
1/2020	Social and medical need for whole genome high resolution NIPT.
1/2020	Nuchal translucency of 3.0-3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review.
12/2019	TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
10/2019	Placental studies elucidate discrepancies between NIPT showing a structural chromosome aberration and a differently abnormal fetal karyotype.
11/2018	Unexpected finding of uniparental disomy mosaicism in term placentas: Is it a common feature in trisomic placentas?
1/2017	The influence of SNP-based chromosomal microarray and NIPT on the diagnostic yield in 10,000 fetuses with and without fetal ultrasound anomalies.
1/2016	False Negative NIPT Results: Risk Figures for Chromosomes 13, 18 and 21 Based on Chorionic Villi Results in 5967 Cases and Literature Review.
1/2016	Enlarged NT (≥3.5 mm) in the first trimester - not all chromosome aberrations can be detected by NIPT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karin E M Diderich Research Topics

Disease

8	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 01/2016
4	Aneuploidy (Aneuploid) 01/2021 - 01/2016
3	Trisomy (Trisomies) 01/2022 - 11/2018
2	Down Syndrome (Down's Syndrome) 01/2021 - 01/2020
1	Sacral defect and anterior sacral meningocele 01/2022
1	Anorectal Malformations 01/2022
1	Malformations of Cortical Development 11/2021
1	Congenital Abnormalities (Deformity) 01/2021
1	Uniparental Disomy 10/2019
1	Osteogenesis Imperfecta (Lobstein Disease) 04/2017
1	Trisomy 18 Syndrome 01/2016
1	Persistent Fetal Circulation Syndrome 06/2013
1	Alveolar capillary dysplasia 06/2013
1	Trichothiodystrophy Syndromes 08/2012
1	Hypoglycemia (Reactive Hypoglycemia) 01/2007
1	Cockayne Syndrome (Syndrome, Cockayne) 01/2007

Drug/Important Bio-Agent (IBA)

10	dichlorobis(azomycin)platinum IIIBA 01/2022 - 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	TubulinIBA 11/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	alpha2 Subunit Collagen Type IIBA 04/2017
1	Collagen Type I (Type I Collagen)IBA 04/2017
1	DNA (Deoxyribonucleic Acid)IBA 06/2013
1	Transcription Factor TFIIHIBA 08/2012
1	Growth Hormone (Somatotropin)IBA 01/2007
1	AntioxidantsIBA 01/2007
1	Insulin-Like PeptidesIBA 01/2007
1	Liver GlycogenIBA 01/2007